Page last updated: 2024-08-17

dichloroacetic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

dichloroacetic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Cheung, E; Hu, X; Lam, YM; Leung, YC; Tam, KY; Verma, A	1

Other Studies

1 other study(ies) available for dichloroacetic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Combined use of arginase and dichloroacetate exhibits anti-proliferative effects in triple negative breast cancer cells. The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; Drug Therapy, Combination; Female; G2 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Triple Negative Breast Neoplasms	2019

Article

Year

Combined use of arginase and dichloroacetate exhibits anti-proliferative effects in triple negative breast cancer cells.

The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; Drug Therapy, Combination; Female; G2 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Triple Negative Breast Neoplasms

2019